Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
作者信息
Logunov Denis Y, Dolzhikova Inna V, Tukhvatullin Amir I, Shcheblyakov Dmitry V
机构信息
N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia.
N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia.
出版信息
Lancet. 2020 Oct 3;396(10256):e54-e55. doi: 10.1016/S0140-6736(20)31970-X. Epub 2020 Sep 21.
Abstract
摘要
相似文献
1
Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
Lancet. 2020 Oct 3;396(10256):e54-e55. doi: 10.1016/S0140-6736(20)31970-X. Epub 2020 Sep 21.
2
Russian SARS-CoV-2 vaccine.
BMJ. 2020 Aug 24;370:m3270. doi: 10.1136/bmj.m3270.
3
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
Lancet. 2020 Nov 7;396(10261):1486-1487. doi: 10.1016/S0140-6736(20)32267-4.
4
Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
Lancet. 2020 Oct 3;396(10256):e53. doi: 10.1016/S0140-6736(20)31960-7. Epub 2020 Sep 21.
5
COVID-19 vaccines: early success and remaining challenges.
Lancet. 2020 Sep 26;396(10255):868-869. doi: 10.1016/S0140-6736(20)31867-5. Epub 2020 Sep 4.
6
The arrival of Sputnik V.
Lancet Infect Dis. 2020 Oct;20(10):1128. doi: 10.1016/S1473-3099(20)30709-X.
7
A vaccine is not too far for COVID-19.
J Infect Dev Ctries. 2020 May 31;14(5):450-453. doi: 10.3855/jidc.12744.
8
Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
N Engl J Med. 2020 Jul 30;383(5):e57. doi: 10.1056/NEJMe2026514.
9
COVID-19 disrupts vaccine delivery.
Lancet Infect Dis. 2020 May;20(5):546. doi: 10.1016/S1473-3099(20)30304-2. Epub 2020 Apr 17.
10
Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2.
J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):517-518. doi: 10.1093/jpids/piaa093.
引用本文的文献
1
immune evaluation of adenoviral vector-based platform for infectious diseases.
BioTechnologia (Pozn). 2023 Dec 21;104(4):403-419. doi: 10.5114/bta.2023.132775. eCollection 2023.
2
Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy.
Viruses. 2023 Feb 24;15(3):621. doi: 10.3390/v15030621.
3
Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study.
BMC Med. 2022 Sep 20;20(1):312. doi: 10.1186/s12916-022-02509-8.
4
Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models.
Mol Immunol. 2022 Sep;149:107-118. doi: 10.1016/j.molimm.2022.06.007. Epub 2022 Jun 23.
5
COVID-19 Vaccination Acceptance Among Chinese Population and Its Implications for the Pandemic: A National Cross-Sectional Study.
Front Public Health. 2022 Feb 8;10:796467. doi: 10.3389/fpubh.2022.796467. eCollection 2022.
6
Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning.
J Med Internet Res. 2021 Nov 29;23(11):e30529. doi: 10.2196/30529.
7
Controversy surrounding the Sputnik V vaccine.
Respir Med. 2021 Oct;187:106569. doi: 10.1016/j.rmed.2021.106569. Epub 2021 Aug 10.
8
Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy - An overview.
Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:106-116. doi: 10.1016/j.ejogrb.2021.06.001. Epub 2021 Jun 15.
9
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial.
Lancet. 2021 May 22;397(10288):1881-1883. doi: 10.1016/S0140-6736(21)00899-0. Epub 2021 May 12.
10
The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.
Med Drug Discov. 2021 Jun;10:100085. doi: 10.1016/j.medidd.2021.100085. Epub 2021 Mar 10.
Zotero 插件